Skip to search formSkip to main contentSkip to account menu

zatosetron maleate

Known as: 7-Benzofurancarboxamide, 5-Chloro-2,3-Dihydro-2,2-Dimethyl-N-(8-Methyl-8-Azabicyclo(3.2.1)Oct-3-yl)-, Endo-, (Z)-2-Butenedioate (1:1) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
The aim of this study was to make a preliminary investigation of the efficacy and safety of zatosetron maleate, a selective 5… 
1995
1995
Recently discovered serotonin3 (5-HT3) receptor antagonists are potent antiemetics in cytotoxic drug-induced vomiting. The… 
1995
1995
The pro-inflammatory lipid mediator leukotriene B 4 (LTB4) is derived from arachidonic acid (AA) metabolism through the… 
1994
1994
The major in vivo human metabolite of zatosetron is 8-alpha-methyl,8-beta-oxo zatosetron [N-O (1) zatosetron]. N-Desmethyl… 
1994
1994
Serotonin receptor (5‐HT3) antagonists provide effective antiemetic therapy in cancer patients receiving emetogenic chemotherapy… 
1992
1992
Antagonists of 5HT3 receptors are clinically effective in treating nausea and emesis associated with certain oncolytic drugs…